- Home
- WFRD vs ITCI Comparison
WFRD vs ITCI Comparison
Compare WFRD & ITCI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- WFRD
- ITCI
- Stock Information
- Founded
- WFRD 1941
- ITCI 2002
- Country
- WFRD United States
- ITCI United States
- Employees
- WFRD N/A
- ITCI N/A
- Industry
- WFRD Metal Fabrications
- ITCI Biotechnology: Pharmaceutical Preparations
- Sector
- WFRD Industrials
- ITCI Health Care
- Exchange
- WFRD Nasdaq
- ITCI Nasdaq
- Market Cap
- WFRD 7.9B
- ITCI 8.0B
- IPO Year
- WFRD N/A
- ITCI N/A
- Fundamental
- Price
- WFRD $85.32
- ITCI $85.45
- Analyst Decision
- WFRD Strong Buy
- ITCI Strong Buy
- Analyst Count
- WFRD 8
- ITCI 12
- Target Price
- WFRD $148.25
- ITCI $97.67
- AVG Volume (30 Days)
- WFRD 957.0K
- ITCI 760.7K
- Earning Date
- WFRD 10-22-2024
- ITCI 10-30-2024
- Dividend Yield
- WFRD 1.17%
- ITCI N/A
- EPS Growth
- WFRD 51.37
- ITCI N/A
- EPS
- WFRD 7.14
- ITCI N/A
- Revenue
- WFRD $5,534,000,000.00
- ITCI $613,728,000.00
- Revenue This Year
- WFRD $11.61
- ITCI $48.25
- Revenue Next Year
- WFRD $3.21
- ITCI $38.47
- P/E Ratio
- WFRD $11.93
- ITCI N/A
- Revenue Growth
- WFRD 11.08
- ITCI 46.08
- 52 Week Low
- WFRD $77.00
- ITCI $58.14
- 52 Week High
- WFRD $135.00
- ITCI $93.45
- Technical
- Relative Strength Index (RSI)
- WFRD 50.36
- ITCI 55.65
- Support Level
- WFRD $80.99
- ITCI $81.83
- Resistance Level
- WFRD $91.82
- ITCI $86.36
- Average True Range (ATR)
- WFRD 3.06
- ITCI 2.54
- MACD
- WFRD 0.23
- ITCI -0.76
- Stochastic Oscillator
- WFRD 52.06
- ITCI 31.15
About WFRD Weatherford International plc
Weatherford International provides diversified oilfield services across international markets for an array of oilfield types. The firm is a global market leader in artificial lift and tubular running services. Other key product lines include cementing products, directional drilling, and wireline evaluation.
About ITCI Intra-Cellular Therapies Inc.
Intra-Cellular Therapies Inc is a biopharmaceutical company that develops novel drugs for treating diseases of the central nervous system. The company is focused on the delivery and clinical development of small-molecule drugs that address needs in neuropsychiatric and neurological disorders. Intra-Cellular maintains proprietary chemistry platforms to develop drugs for neurodegenerative diseases. The company's business segment is discovering and developing drugs for the treatment of neurological and psychiatric disorders.